Literature DB >> 19931576

Construction of synthetic open reading frame encoding human interferon alpha 2b for high expression in Escherichia coli and characterization of its gene product.

Debbie S Retnoningrum1, Ratih A Ningrum, Yohanes N Kurniawan, Ana Indrayati, Heni Rachmawati.   

Abstract

The aim of this research was to obtain recombinant human interferon alpha 2b (rhIFNalpha2b) from a synthetic open reading frame (ORF) overexpressed in Escherichia coli. For gene assembly, oligonucleotides were designed by Thermodynamically Balanced Inside Out (TBIO) method using the published synthetic codon optimized hIFNalpha2b ORF for high expression in E. coli. The synthetic ORF was assembled by a two-step Polymerase Chain Reaction (PCR) and cloned into a pGEM-T vector. The two-step PCR resulted in a DNA band of 522 base pairs (bp) corresponding to the size of hIFNalpha2b ORF. Fifteen recombinant pGEM-Ts were obtained and the sequencing results showed that the ORFs contained one to ten mutations with an error rate of 8.3 per kilo base. An ORF carrying one mutation was cloned into a pET32b vector and site-directed mutagenesis was performed to correct the mutation. The hIFNalpha2b ORF was overexpressed as a thioredoxin-his-tag fusion protein in E. coli BL21. The rhIFNalpha2b fusion protein was isolated from inclusion bodies (IB), renatured, and purified using Nickel columns, and all steps were monitored by Sodium Dodecyl Sulphate Polyacrylamide Gel Electrophoresis (SDS-PAGE). A rhIFNalpha2b fusion protein of 37kDa in size was produced in high expression levels relative to total protein, renatured and purified from IB with a yield of 3.46mg/l without any further optimization. The purified rhIFNalpha2b was confirmed by peptide analysis with nano-LC-MS/MS2 mass spectrometry. Our current research demonstrates for the first time that by using the TBIO method a synthetic ORF encoding hIFNalpha2b gene can be expressed at high levels in E. coli.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19931576     DOI: 10.1016/j.jbiotec.2009.11.008

Source DB:  PubMed          Journal:  J Biotechnol        ISSN: 0168-1656            Impact factor:   3.307


  5 in total

1.  High-level expression of a novel liver-targeting fusion interferon with preferred Escherichia coli codon preference and its anti-hepatitis B virus activity in vivo.

Authors:  Xuemei Lu; Jie Wang; Xiaobao Jin; Jiayong Zhu
Journal:  BMC Biotechnol       Date:  2015-06-12       Impact factor: 2.563

2.  Evaluation of adverse effects of mutein forms of recombinant human interferon alpha-2b in female swiss webster mice.

Authors:  H Rachmawati; A Merika; R A Ningrum; K Anggadiredja; D S Retnoningrum
Journal:  Biomed Res Int       Date:  2013-05-02       Impact factor: 3.411

3.  Heterologous expression, immunochemical and computational analysis of recombinant human interferon alpha 2b.

Authors:  Iram Gull; Zahoor Qadir Samra; Muhammad Shahbaz Aslam; Muhammad Amin Athar
Journal:  Springerplus       Date:  2013-06-15

4.  Construction of a novel liver-targeting fusion interferon by incorporation of a Plasmodium region I-plus peptide.

Authors:  Xuemei Lu; Xiaobao Jin; Yanting Huang; Jie Wang; Juan Shen; Fujiang Chu; Hanfang Mei; Yan Ma; Jiayong Zhu
Journal:  Biomed Res Int       Date:  2014-01-19       Impact factor: 3.411

5.  Removing a Cystein Group On Interferon Alpha 2b at Position 2 and 99 does Not Diminish Antitumor Activity of the Protein, Even Better.

Authors:  Heni Rachmawati; Adhitya Jessica; Yeyet Cahyati Sumirtaputra; Debbie Sofie Retnoningrum; Amirah Adlia; Ratih Asmana Ningrum
Journal:  Sci Pharm       Date:  2016-02-14
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.